Global Lung Cancer Surgery Market Size, Share, and Forecast Analysis 2025-2029

Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.

What Are the Lung Cancer Surgery Market Size Forecast for 2025?
Significant growth has been observed in recent years in the lung cancer surgery market size. The market is predicted to expand from $5.07 billion in 2024 to $5.33 billion in 2025, revealing a compound annual growth rate (CAGR) of 5.1%. Factors contributing to this growth during the historic period include a high prevalence of smoking, increasing incidents of lung cancer, development in hospital infrastructure, expansion in insurance coverage, and enhancement in surgeon expertise.

What Is the Market Size Outlook for Lung Cancer Surgery Until 2029?
Stable expansion is anticipated in the lung cancer surgery market size in the upcoming years. It is set to rise to $6.43 billion by 2029, growing at a compound annual growth rate (CAGR) of 4.8%. This projected growth over the forecast period can be linked to factors such as the growing elderly population worldwide, an increase in non-small cell lung cancer instances, enhanced awareness in developing nations, a rise in the use of robotic surgical platforms, and amplified investments in cancer care. The forthcoming period will witness trends such as robotic-assisted thoracic surgery, augmented reality application in surgeries, the use of 3D printing for surgical simulation, artificial intelligence in surgical planning, and intelligent surgical tools.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report

What Are the Major Factors Driving Demand in the Lung Cancer Surgery Market?
The lung cancer surgery market is anticipated to expand due to the rising occurrence of lung cancer. This type of cancer, typified by irregular cell growth in one or both lungs, affects normal lung functionality. The pollution in the air and prime particulate matter to which people are exposed over long periods is augmenting the risk of lung cancer, given that these micro-particles can infiltrate the lungs in depth and cause inflammation, cell deterioration, and mutation, potentially leading to cancer. Lung cancer surgeries enable us to curb the death toll related to lung cancer by facilitating the early excision of malignant tumors before they proliferate or advance. The Centers for Disease Control and Prevention, a government agency in the US, cited in June 2025 that lung cancer was the cause of 131,584 deaths in the country in 2023, after 218,893 cases were reported new in 2022. Consequently, the escalating prevalence of lung cancer is driving the growth of the lung cancer surgery market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25816&type=smp

How Are End-Use Segments Shaping the Lung Cancer Surgery Market Outlook?
The lung cancer surgery market covered in this report is segmented -

1) By Type: Minimally Invasive Surgeries
2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction
3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments
4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels
5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users

Subsegments:
1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection
2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

What Are the Strategic Trends Transforming the Lung Cancer Surgery Market Landscape?
Significant players in the lung cancer surgery market, such as Johnson & Johnson MedTech, are concentrating on the creation of advanced technology like robotic-assisted surgeries. These technologies enhance the accuracy of surgeries, minimise recovery time and boost patient results. Robotic-assisted surgical methods refer to those procedures which utilize robotic systems, controlled by surgeons, to augment precision, lessen complications, and better patient recovery outcomes. A prime illustration being in March 2025, when Johnson & Johnson MedTech, reportedly received approval for MONARCH QUEST from under U.S. 510(k). This robotic-assisted bronchoscopy technology offers superior reach and stability for accessing tiny lung nodules which are typically hard to reach, thereby augmenting the ability to detect lung cancer at a premature stage. It provides improved maneuverability and blends seamlessly with imaging technologies for accurate biopsies, causing minimal discomfort to the patients. MONARCH QUEST is designed to broaden the scope of procedures and improve workflow efficiency. It lends greater clinical confidence and consistency across an extensive array of bronchoscopic procedures.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25816&type=smp

Who Are the Prominent Companies in the Lung Cancer Surgery Market by ?
Major companies operating in the lung cancer surgery market are Johnson & Johnson, Medtronic plc, Siemens Healthcare GmbH, Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Teleflex Incorporated, Varian Medical Systems Inc., Karl Storz SE, Lepu Medical Technology (Beijing) Co. Ltd., Ambu A/S, Accuray Incorporated, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc., AngioDynamics Inc., Ackermann Instrument GmbH, Scanlan International Inc., Sontec Instruments Inc., Covidien LLC

Which Region Is Expected to See the Highest CAGR in the Lung Cancer Surgery Market?
North America was the largest region in the lung cancer surgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.